Article
Citigroup Maintains Sell on Hims & Hers Health, Lowers Price Target to $16.5
Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Sell and lowers the price target from $30 to $16.5.
Comments
- No comments yet. Be the first to comment!